Edition:
United Kingdom

Celldex Therapeutics Inc (CLDX.OQ)

CLDX.OQ on NASDAQ Stock Exchange Capital Market

2.36USD
21 Aug 2019
Change (% chg)

-- (--)
Prev Close
$2.36
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
53,427
52-wk High
$11.55
52-wk Low
$2.02

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -1.21 December 22 Aug 2019

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 0 0 0 0
(2) OUTPERFORM 1 1 1 1
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.00 2.00 2.00 2.00

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-19 1 1.26 1.26 1.26 --
Quarter Ending Dec-19 1 1.10 1.10 1.10 --
Year Ending Dec-19 1 5.10 5.10 5.10 6.83
Year Ending Dec-20 1 6.00 6.00 6.00 7.13
Earnings (per share)
Quarter Ending Sep-19 1 -1.21 -1.21 -1.21 --
Quarter Ending Dec-19 1 -1.05 -1.05 -1.05 --
Year Ending Dec-19 1 -4.80 -4.80 -4.80 -8.70
Year Ending Dec-20 1 -3.69 -3.69 -3.69 -8.65

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-19 1.23 1.42 0.19 15.85
Quarter Ending Dec-18 1.46 1.76 0.30 20.82
Quarter Ending Sep-18 1.89 0.94 0.95 50.21
Quarter Ending Jun-18 2.30 2.76 0.47 20.30
Quarter Ending Mar-18 2.31 4.07 1.76 76.30

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-19 1.26 1.26 1.26 1.26 --
Quarter Ending Dec-19 1.10 1.10 1.10 1.10 --
Year Ending Dec-19 5.10 5.10 5.10 5.10 6.83
Year Ending Dec-20 6.00 6.00 6.00 6.00 7.13

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-19 0 0 0 0
Quarter Ending Dec-19 0 0 0 0
Year Ending Dec-19 0 0 0 0
Year Ending Dec-20 0 0 0 0
Earnings